ACS Chemical Biology · 2013 · 56 citations · 14 references
Life SciencesMedicinal ChemistryOncologyDna RepairDrug DiscoveryEnzymologyEnzyme FunctionEnzyme InhibitionInhibitor SelectivityParp InhibitionPoly Adp-ribose Polymerase InhibitorsPoly(adp-ribose) Polymerase 1Poly(adp-ribose) Polymerase ActivityPoly(adp-ribose) Polymerase InhibitionPoly(adp-ribose) Polymerase InhibitorsPoly(adp-ribose) Polymerase-mediated Repair
Inhibiting ADP-ribosyl transferases with PARP-inhibitors is considered a promising strategy for the treatment of many cancers and ischemia, but most of the cellular targets are poorly characterized. Here, we describe an inhibitor of ADP-ribosyltransferase-3/poly(ADP-ribose) polymerase-3 (ARTD3), a regulator of DNA repair and mitotic progression. In vitro profiling against 12 members of the enzyme family suggests selectivity for ARTD3, and crystal structures illustrate the molecular basis for inhibitor selectivity. The compound is active in cells, where it elicits ARTD3-specific effects at submicromolar concentration. Our results show that by targeting the nicotinamide binding site, selective inhibition can be achieved among the closest relatives of the validated clinical target, ADP-ribosyltransferase-1/poly(ADP-ribose) polymerase-1.
14
Features and development of <i>Coot</i>
Paul Emsley, Bernhard Lohkamp, W. G. Scott et al. · Acta Crystallographica Section D Biological Crystallography · 2010 · 29.6K citations · Full text
Wolfgang Kabsch · Acta Crystallographica Section D Biological Crystallography · 2010 · 16.9K citations · Full text
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
E. Wahlberg, T. Karlberg, E. Kouznetsova et al. · Nature Biotechnology · 2012 · 460 citations